Skip to main content
OpenTrials
Completed

NCT Number: NCT05375656

The Effect on Metabolism, Food Intake and Preferences of a Knockout Gene Variant Involved in Carbohydrate Metabolism

Around 10% has type 2 diabetes in Greenland, despite being a practically unknown disease only six decades ago. The drastic increase is of great concern, especially considering the transition that have occurred during the same decades going from a fisher-hunter lifestyle towards a more western lifestyle. Today, traditional marine foods are still increasingly being replaced by imported foods high in refined sugar (sucrose) and starch. Furthermore, recent studies discovered that the Greenlandic population harbors a different genetic architecture behind type 2 diabetes. Hence, obtaining more knowledge on interactions between lifestyle, genetics, and metabolism is therefore crucial in order to ameliorate the growing curve, or maybe even turn it around.

Sucrose intolerance is in general rare; however, it is a common condition in Greenland and other Inuit populations. Here it is caused by a genetic variant in the sucrase-isomaltase (SI) gene, resulting in complete loss of enzyme function and hence an inability to digest sucrose and some of the glycosidic bonds in starch, both carbohydrates that are not part of the traditional Inuit diet. A recent, unpublished study found the variant to be associated with lower BMI, body fat percentage, bodyweight, and lipid levels independent of the lower intake of refined sugar. This might be explained by differences in the metabolism of carbohydrates and in the gut microbiota. The healthier phenotype was confirmed by a SI knockout mouse model, which furthermore interestingly indicated that the variant might alter food and taste preferences.

It is anticipated that the drastic increase in type 2 diabetes in Greenland can be explained at least partly by the complex interaction between lifestyle and genetics. Therefore, the aim is to investigate if metabolic and microbial differences can explain the healthier phenotype of the homozygous carriers of the SI variant than wildtype individuals amd perform a 3-day cross-over dietary intervention using assigning subjects to a traditional Greenlandic diet and a Western diet. Moreover, the aim is to assess whether their food and taste preferences are different. The study will help us to understand the complex interactions between lifestyle, behavior, genetics, the microbiota and the host metabolism.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Maniitsoq Healthcare Center, Maniitsoq, Greenland

Loading trial locations.

About this study

In this human study, effects of the SI knockout variant on metabolism, dietary habits and food preferences will be quantified. The study will be unique by being the first assessing the effect of a complete loss of SI function, which it is only feasible in Arctic populations.

Differences between homozygous (HO) carriers and heterozygous (HE)/wildtype (WT) individuals are suspected to be large on a carbohydrate-rich diet and small on a traditional diet. The following hypotheses will be addressed:

HO carriers metabolize carbohydrates differently than HE+WT individuals:

  • HO have a lower glycemic variability on their habitual diet than WT+HE.
  • HO have a lower glycemic variability on a starch and sucrose rich diet than WT+HE.
  • HO have a glycemic variability similar to WT+HE on a traditional diet low in carbohydrates.

HO carriers have different food preferences than HE+WT individuals:

  • HO have a lower sweet taste preference compared to WT+HE.
  • HO perceive iso-intense solutions of sucrose, fructose, and glucose differently in sweet taste intensity and WT+HE will perceive them iso-intense.
  • HO consume less high-sugar-low-fat foods than WT+HE.
  • HO have similar intake and preference for high-sugar-high-fat foods as WT+HE.

HO carriers have a microbiota different from HE+WT individuals:

  • Diversity and abundance of starch-fermenting bacteria is higher in HO than in WT+HE and the abundance of Parabacteroides is lower.
  • The increase in starch-fermenting bacteria as well as fecal and circulating levels of short chain fatty acids is larger for HO than in WT+HE on a starch and sucrose rich diet.
  • A diet low in carbohydrates will alter the microbiota similarly for HO and WT+HE.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Homozygous carriers of the c.273_274delAG variant in the SI-gene (cases)
  • Homozygous non-carriers of the c.273_274delAG variant in the SI-gene (controls)

Exclusion criteria

  • Diagnosis of diabetes or pharmacological treatment of diabetes.
  • Gastrointestinal diseases such as inflammatory bowel disease, gastrointestinal cancer, and ulcer. Persons with mild gastrointestinal problems are not excluded, e.g. persons with lactose-intolerance who normally do not have any gastrointestinal problems.
  • Homozygous carriers of the TBC1D4 risk variant p.Arg684Ter.
  • Lack of compliance with the procedures in the study protocol, judged by Investigator.
  • For the homozygous carriers of the c.273_274delAG variant: rise in blood glucose in an oral sucrose tolerance test.

Treatment and study plan

Cross-over study

Other

Traditional Inuit Diet and Western Diet.

Primary outcomes

  1. Glycemic variability during Western diet

    Time frame: During the 3 days of intervention with Western diet.

    Glycemic variability will be measured by mean amplitude of glycemic excursions (MAGE) during the whole study period, i.e. during both Western and Inuit diet and the wash-out period in between.

  2. Glycemic variability during Inuit diet

    Time frame: During the 3 days of intervention with Inuit diet.

    Glycemic variability will be measured by mean amplitude of glycemic excursions (MAGE) during the whole study period, i.e. during both Western and Inuit diet and the wash-out period in between.

Secondary outcomes

  1. Sweet Bias Score

    Time frame: Baseline (to assess differences between genotypes, independent of the intervention)

    As a food reward measure, explicit liking for foods with sweet relative to savory taste will be assessed using the Leeds Food Preference Questionnaire. A sweet bias score will be estimated, where a positive score indicates higher preference for sweet relative to savoury foods and a negative score indicates higher preference for savoury foods.

  2. Fat Bias Score

    Time frame: Baseline (to assess differences between genotypes, independent of the intervention)

    As a food reward measure, explicit liking for foods with high-fat relative to low-fat content will be assessed using the Leeds Food Preference Questionnaire. A fat bias score will be estimated, where a positive score indicates higher preference for high-fat relative to low-fat foods and a negative score indicates higher preference for low-fat foods.

  3. High-fat savory preference

    Time frame: Baseline (to assess differences between genotypes, independent of the intervention)

    As a food reward measure, explicit liking for high-fat savory foods will be assessed in the Leeds Food Preference Questionnaire. The average rating from 0-100 on the visual analogue scale is calculated for all four foods within the food category.

  4. Low-fat savory preference

    Time frame: Baseline (to assess differences between genotypes, independent of the intervention)

    As a food reward measure, explicit liking for low-fat savory foods will be assessed in the Leeds Food Preference Questionnaire. The average rating from 0-100 on the visual analogue scale is calculated for all four foods within the food category.

  5. High-fat sweet preference

    Time frame: Baseline (to assess differences between genotypes, independent of the intervention)

    As a food reward measure, explicit liking for high-fat sweet foods will be assessed in the Leeds Food Preference Questionnaire. The average rating from 0-100 on the visual analogue scale is calculated for all four foods within the food category.

  6. Low-fat sweet preference

    Time frame: Baseline (to assess differences between genotypes, independent of the intervention)

    As a food reward measure, explicit liking for low-fat sweet foods will be assessed in the Leeds Food Preference Questionnaire. The average rating from 0-100 on the visual analogue scale is calculated for all four foods within the food category.

  7. Implicit wanting score: High-fat savory foods

    Time frame: Baseline (to assess differences between genotypes, independent of the intervention)

    As a food reward measure, implicit wanting for high-fat savory foods will be assessed using the Leeds Food Preference Questionnaire.

    The 'implicit wanting' score is calculated based on a combination of reaction time and choice or non-choice of foods in the forced choice paradigm. A positive score indicates a higher preference for this food category compared to the other food categories, and a negative score indicates a lower preference for this food category.

  8. Implicit wanting score: Low-fat savory foods

    Time frame: Baseline (to assess differences between genotypes, independent of the intervention)

    As a food reward measure, implicit wanting for low-fat savory foods will be assessed using the Leeds Food Preference Questionnaire.

    The 'implicit wanting' score is calculated based on a combination of reaction time and choice or non-choice of foods in the forced choice paradigm. A positive score indicates a higher preference for this food category compared to the other food categories, and a negative score indicates a lower preference for this food category.

  9. Implicit wanting score: High-fat sweet foods

    Time frame: Baseline (to assess differences between genotypes, independent of the intervention)

    As a food reward measure, implicit wanting for high-fat sweet foods will be assessed using the Leeds Food Preference Questionnaire.

    The 'implicit wanting' score is calculated based on a combination of reaction time and choice or non-choice of foods in the forced choice paradigm. A positive score indicates a higher preference for this food category compared to the other food categories, and a negative score indicates a lower preference for this food category.

  10. Implicit wanting score: Low-fat sweet foods

    Time frame: Baseline (to assess differences between genotypes, independent of the intervention)

    As a food reward measure, implicit wanting for low-fat sweet foods will be assessed using the Leeds Food Preference Questionnaire.

    The 'implicit wanting' score is calculated based on a combination of reaction time and choice or non-choice of foods in the forced choice paradigm. A positive score indicates a higher preference for this food category compared to the other food categories, and a negative score indicates a lower preference for this food category.

  11. Habitual diet

    Time frame: Baseline (to assess differences between genotypes, independent of the intervention)

    Habitual dietary intake will be assessed using a food frequency questionnaire. Macronutrient composition and content of sugar will be assessed as well as characterization of differences in food choice with respect to sweet foods and foods rich in starch. Intake will be expressed in g/day as well as E%.

  12. Intake in a snacking test meal

    Time frame: Baseline (to assess differences between genotypes, independent of the intervention)

    Using an ad libitum snacking test meal, preferences will be assessed for sweet-taste and content of sucrose and fat as well as other sweeteners than sucrose, e.g. honey.

  13. Sucrose sweetness sensitivity

    Time frame: Baseline (to assess differences between genotypes, independent of the intervention)

    Ability to taste a difference between iso-intense solutions of sucrose and fructose+glucose using a 2-alternative forced choice test

  14. Sweet liking

    Time frame: Baseline (to assess differences between genotypes, independent of the intervention)

    Hedonic rating of liking of iso-intense solutions of sucrose, fructose, glucose and fructose+glucose using a visual analogue scale (0-100 mm)

  15. Perceived intensity of sugars

    Time frame: Baseline (to assess differences between genotypes, independent of the intervention)

    Hedonic rating of perceived intensity of iso-intense solutions of sucrose, fructose, glucose and fructose+glucos using a visual analogue scale (0-100 mm)

  16. Plasma lipids

    Time frame: The day before and the day after each dietary intervention period.

    Changes in fasting plasma measures of VLDL-cholesterol, LDL-cholesterol, HDL-cholesterol, total cholesterol, remnant cholesterol, and triglycerides

  17. Serum insulin

    Time frame: The day before and the day after each dietary intervention period.

    Changes in serum insulin. Fasting sample.

  18. Plasma CRP

    Time frame: The day before and the day after each dietary intervention period.

    Changes in plasma CRP. Fasting sample.

  19. Plasma acetate

    Time frame: The day before and the day after each dietary intervention period.

    Changes in plasma acetate. Fasting sample.

  20. Plasma propionate

    Time frame: The day before and the day after each dietary intervention period.

    Changes in plasma propionate. Fasting sample.

  21. Plasma butyrate

    Time frame: The day before and the day after each dietary intervention period.

    Changes in plasma butyrate. Fasting sample.

  22. HbA1c

    Time frame: Baseline

    Fasting glycated hemoglobin

  23. Fecal acetate

    Time frame: Before and on the last day or on the day after each dietary intervention period.

    Changes in fecal acetate.

  24. Fecal propionate

    Time frame: Before and on the last day or on the day after each dietary intervention period.

    Changes in fecal propionate.

  25. Fecal butyrate

    Time frame: Before and on the last day or on the day after each dietary intervention period.

    Changes in fecal butyrate.

  26. Fecal pH

    Time frame: Before and on the last day or on the day after each dietary intervention period.

    pH of fecal samples.

  27. Changes in gut microbiota composition

    Time frame: Before and on the last day or on the day after each dietary intervention period.

    Changes in gut microbiota composition between baseline and end of each dietary intervention period. Microbiota composition is measured by genome sequencing fecal samples.

  28. Baseline gut microbiota composition

    Time frame: Before intervention (baseline).

    Characterization of the gut microbiota composition. Microbiota composition is measured by genome sequencing fecal samples.

  29. Fecal carbohydrates

    Time frame: Before and on the last day or on the day after each dietary intervention period.

    Content of carbohydrates in fecal samples and changes in this during the intervention periods.

  30. Glycemic variability during habitual diet

    Time frame: Measured during 7 days of wash-out

    Glycemic variability will be measured by mean amplitude of glycemic excursions (MAGE)

Other outcomes

  1. Body weight

    Time frame: Baseline (participant characteristics)

    Weight (kg). Measured when the participant is wearing light underwear.

  2. Height

    Time frame: Baseline (participant characteristics)

    Height (cm). Measured when the participant is not wearing shoes.

  3. Hip circumference

    Time frame: Baseline (participant characteristics)

    Hip circumference (cm). Measured when the participant is wearing light underwear.

  4. Waist circumference

    Time frame: Baseline (participant characteristics)

    Waist circumference (cm). Measured when the participant is wearing light underwear.

  5. Body composition

    Time frame: Baseline (participant characteristics)

    Body fat percentage measured using a Tanita body composition analyser.

  6. Plasma lipodomics.

    Time frame: The day before and the day after each dietary intervention period.

    For future analyses

  7. Plasma metabolomics.

    Time frame: The day before and the day after each dietary intervention period.

    For future analyses

  8. Plasma proteomics.

    Time frame: The day before and the day after each dietary intervention period.

    For future analyses

  9. Fecal lipodomics

    Time frame: The day before and the day after each dietary intervention period.

    For future analyses

  10. Fecal metabolomics.

    Time frame: The day before and the day after each dietary intervention period.

    For future analyses

  11. Fecal proteomics.

    Time frame: The day before and the day after each dietary intervention period.

    For future analyses

Sponsors and collaborators

Lead sponsor

Steno Diabetes Center Copenhagen

Other

Collaborators

  • Steno Diabetes Center Greenland
  • The Novo Nordisk Foundation Center for Basic Metabolic Research
  • University of Copenhagen

Registry information

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
May 17, 2022
Registry last updated
May 31, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.